New investors, naked shorting is almost nonexistent in IPIX

New Post Public Reply Private Reply Replies (1) Message Board
sox0407
433
New investors, naked shorting is almost nonexistent in IPIX and here’s why.

Reason #1 - SEC Failure-to-deliver Data

“In a “naked” short sale, the seller does not borrow or arrange to borrow the securities in time to make delivery to the buyer within the standard two-day settlement period. As a result, the seller fails to deliver securities to the buyer when delivery is due ( known as a “failure to deliver” or “fail” ).”

https://www.sec.gov/investor/pubs/regsho.htm

According to the SEC, only 6945 shares (0.005% of the OS) were failure-to-deliver as of February 28.

20180228|45782D100|IPIX| 6945 |INNOVATION PHARMACEU|0.63

https://www.sec.gov/data/foiadocsfailsdatahtm

Reason #2 - Name/CUSIP # Change

"Changing the stock cusip number results in each share with the old cusip number having to be exchanged for a share with the new cusip number, which causes each short position to have to prove the borrow. Naked short positions would be unable to comply and those positions could have to be covered by purchasing shares with the new cusip on the open market. "

https://groovevc.wordpress.com/2017/04/12/is-...t-squeeze/

"Both your transfer agent and IR firm should be able to advise you on the effectiveness of combating naked shorts by changing CUSIP numbers, reverse mergers, and/or reverse splits. Although the long-term effectiveness of these strategies is questionable, it may be useful as part of a larger strategy to deter naked shorting. After changing your company's CUSIP number, for instance, all existing stock certificates must be exchanged for new ones. All issued and outstanding certificates from old shares will no longer represent an interest in the company until exchanged. "

http://www.hawkassociates.com/ir/white/shorts.cfm

Leo decided to change the company name and CUSIP # to expose naked shorting on June 9, 2017. The total volume after the name/CUSIP # change (+3 days) was ~1.625M shares, which indicated the covering was by legal shorts because legal short interest was ~1.2M shares at that time. If naked positions were 10M shares (hypothetical), the total volume would be more than that because naked shorts must cover. For example,

Amarantus - massive covering by naked shorts after name/CUSIP # change.

https://investorshangout.com/post/view?id=4897607

Leo’s legal advisor includes Michael Sullivan, a former US Attorney for MA with connections to the SEC , so his method to expose naked shorting must have some merits.

Reason #3 - No Actual Evidence

By actual evidence I mean official SEC data or something that can be used in court. Proponents will claim IPIX is under attack by sharing naked shorting articles, videos and court cases. Here’s an analogy - just because there’re thieves (naked shorts) in my neighborhood (other companies) doesn’t mean there’re thieves in my house (IPIX). If Leo is suing naked shorts, he’s going to need actual evidences. He can’t just say his company is under attack because other companies are under attack or naked shorting exists in general in court.

Investors should know where the constant selling pressure is coming from.

https://investorshangout.com/post/view?id=4963550

Caution by SEC

11. I read on an internet chat room or website that a specific security has a large number of fails; are these sources reliable?

" Investors can and should verify the number of failures to deliver in a specific security by checking publicly available data on failures to deliver . The Commission publishes on its website failures to deliver data for all equity securities, regardless of the fails level, twice per month. For current failures to deliver information, see http://www.sec.gov/foia/docs/failsdata.htm.

Investors should always be cautious that issuers, promoters, or shareholders may be seeking to stimulate buying interest by making false, misleading or unfounded statements in internet chat rooms or other such forums about alleged large “naked” short positions in some smaller issuers. Some individuals may encourage other investors to buy these issuers’ securities by claiming that there will be an imminent short squeeze, in which the alleged “naked” short sellers will be forced to cover open short positions at increasing prices. These claims in fact may be false.

https://www.sec.gov/investor/pubs/regsho.htm

Action by SEC

2017 - Millennium Settles Charges of Illegal Short Selling in Advance of Stock Offerings
https://www.sec.gov/news/press-release/2017-203

2016 - Case Sheds Light on Goldman’s Role as Lender in Short Sales
https://www.nytimes.com/2016/01/31/business/c...sales.html

2015 - SEC Charges Six Firms for Short Selling Violations in Advance of Stock Offerings
https://www.sec.gov/news/pressrelease/2015-239.html

2014 - SEC Charges Two College Professors in Naked Short Selling Scheme
https://www.sec.gov/news/press-release/2014-20

2013 - SEC Charges 23 Firms With Short Selling Violations in Crackdown on Potential Manipulation in Advance of Stock Offerings
https://www.sec.gov/news/press-release/2013-182

2012 - SEC Charges Brothers With Short Selling Violations
https://www.sec.gov/news/press-release/2012-2012-22htm

Action by FINRA

"In 2017, through our aggressive vigilance, we brought 1,369 disciplinary actions against registered brokers and firms. We levied $66.8 million in fines. And we ordered $66.8 million in restitution to harmed investors. We also referred more than 850 fraud and insider trading cases to the SEC and other agencies for litigation and/or prosecution."

Disciplinary actions - https://www.finra.org/industry/decisions

Fraud and insider trading cases - https://www.finra.org/newsroom/actions-result...uthorities

https://www.finra.org/about

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Dont-give-up.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Arclin's Bold Bet: Expanding Nomex Capacity in Spain

Updated Category News Views 5

Arclin's Strategic Move for Nomex® Expansion Looks like Arclin’s not messing around. They're throwing some serious cash down in Asturias, Spain, to ramp up production of Nomex®—a material hotter than a blacktop in July with demand surging across aerospace, electric vehicles, and defense sectors. "When we bought the Nomex® business, we committed to investing in its...

Continue Reading
Unicycive Faces Stock Plunge and Legal Woes After FDA Setback

Updated Category News Views 5

Unicycive's Rough Ride: Not Just a Bump Picture this: Your stock takes a nosedive over 39% in a day, just after a critical drug application gets slammed by the FDA—for the second time. That’s the story with Unicycive Therapeutics, Inc., ticker NASDAQ: UNC, a company that's been handing out one nail-biting moment after another to its investors. It's not just a minor...

Continue Reading
ELEGOO's M1 Ultra: Bridging Gap in 3D Scanning Tech

Updated Category News Views 0

A Leap in 3D Scanning: Say Hello to M1 Ultra ELEGOO isn't just fiddling with a toy here—this Shenzhen-based juggernaut is rolling out the M1 Ultra on October 29, 2026, and it's causing quite a stir. While the stock market doesn't see immediate tremors from every shiny new gadget, there’s something to say when a company that pulled over $300 million in sales last year...

Continue Reading
Side Bolsters Art Division with Roboto Acquisition

Updated Category News Views 7

Breaking Into China's Game Art Market The gaming industry's latest buzz centers around Side's acquisition of Roboto Entertainment, a boutique art studio known for crafting immersive game environments. This isn't just another headline grab—this move puts Side smack dab in the heart of China's burgeoning game market with a fresh Chengdu base. Expansion With Strategic...

Continue Reading
S&T Bancorp Hits Record Highs in Q3 2026

Updated Category News Views 3

Surpassing Expectations with Record Metrics Well, if it isn’t another stellar quarter for S&T Bancorp (NASDAQ:STBA). The folks over in Indiana, PA, just threw down some serious numbers. The third quarter of 2026 saw net income climbing to $38.6 million, up from $36.6 million last quarter. That's a decent hike if you ask me. But what really stole the spotlight here was...

Continue Reading
Savarese Joins RID to Drive Diagnostic Innovation

Updated Category News Views 5

A Seasoned Leader Bolsters RID's Ambitions Mario Savarese has joined Rapid Infection Diagnostics Inc.'s Strategic Advisory Board, and let me tell ya, this move's got potential. Appointing a heavyweight like Savarese as an advisor isn’t just a nod to his hefty resume. It’s about vaulting a burgeoning company into the big leagues. He's got over 20 years steering a ship...

Continue Reading
Tairex's AI System Targets Global Healthcare Gaps

Updated Category News Views 6

AI Meets Human Expertise in Clinical Decision-Making Look, in the labyrinth of healthcare, we’re seeing a revolution with AI stepping in—not to replace the doctor, but to stand alongside them like a trusty assistant. Tairex, from the halls of Tsinghua University's Institute for AI Industry Research (AIR), has thrown its hat into this ring by unveiling their...

Continue Reading
Montega Kicks Off Agilyx Sponsored Equity Research

Updated Category News Views 1

A Fresh Take on Agilyx's Market Standing Alright, folks. Agilyx ASA just got a new ticket for the analytical rodeo as Montega AG dives into sponsored equity research on the company. For those who aren't fluent in the arcane dialect of stock enthusiasts like yours truly, this means Agilyx now has another sharp set of eyes evaluating their every move, and let me tell you,...

Continue Reading
Nel ASA Welcomes Morten Holum as New CEO by 2027

Updated Category News Views 7

Nel ASA's New Leader Announced In the latest shake-up at Nel ASA (OSE: NEL), Morten Holum is getting ready to take the reins as CEO. By May 1, 2027, Holum will step into the shoes left by Håkon Volldal. And folks, this isn't your average leadership swap. Holum brings a hefty toolkit to this hydrogen powerhouse, having been part of the action across the hydrogen value...

Continue Reading
Amcor's Q3 2026 Results Loom: What's at Stake?

Updated Category News Views 3

Anticipation Builds for Amcor's Q3 2026 Financials Well, here we are again, staring down the barrel of another quarterly earnings report from Amcor plc (NYSE: AMCR). They've circled November 4th, 2026, in red on their calendars to dish out the numbers after the U.S. market's last bell rings. Investors, analysts, and the peanut gallery will be tuning in, and why not? At a...

Continue Reading

Top 5 Most Recently Viewed Articles

Freeport-McMoRan Legal Update: Key Actions for Investors

Updated Category News Views 256

Understanding the Importance of Class Actions for Investors In the world of investing, class actions serve as crucial tools for holding companies accountable for their actions. Investors, particularly those who have purchased stocks during a defined time frame, like those involved with Freeport-McMoRan Inc. (NYSE: FCX), stand to benefit significantly from these legal...

Continue Reading
Investigation into ADMA Biologics Growth Potential and Risks

Updated Category News Views 58

Insights into ADMA Biologics and Ongoing Investigations Investors interested in ADMA Biologics, Inc. should be aware that the company is currently under investigation for potential securities fraud, prompting discussions about recovery options for those impacted. Understanding these developments can offer investors crucial insights into the company's future prospects and...

Continue Reading
Kuehn Law Assists Zentalis Pharmaceuticals Investors in Rights Endeavors

Updated Category News Views 82

Understanding Your Rights as a Zentalis Investor Kuehn Law, a prominent shareholder litigation firm, is currently investigating the actions of the management team at Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL). The focus lies on whether certain officers and directors have acted in ways that undermine their fiduciary responsibilities. These responsibilities include...

Continue Reading
Navigating Market Challenges: Insights into Recent Trends

Updated Category News Views 180

Understanding Current Market Dynamics In a time of significant market fluctuations, risk assets are facing pressure due to a complex mix of economic indicators and investor sentiment. Recent developments in US equities have created a landscape where volatility is the norm. This analysis will delve into various market segments, focusing on key events that shape the current...

Continue Reading
Harnessing Waste Heat: The Future of Clean Energy Deployment

Updated Category News Views 102

Harnessing Waste Heat to Drive Clean Energy Solutions ATS Energy, a trailblazer in renewable energy technology, is making significant strides in turning industrial waste heat into valuable electricity. This revolutionary process not only enhances energy efficiency but also contributes to a more sustainable future. The introduction of the bipartisan Waste Heat to Wattage...

Continue Reading